A
Price
$146.93
Change
+$3.81 (+2.66%)
Updated
Sep 11 closing price
Capitalization
41.42B
79 days until earnings call
Intraday BUY SELL Signals
OPK
Price
$1.57
Change
+$0.08 (+5.37%)
Updated
Sep 11 closing price
Capitalization
1.17B
60 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

A vs OPK

A vs OPK Comparison Chart in %
View a ticker or compare two or three
VS
A vs. OPK commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Hold and OPK is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($41.4B) has a higher market cap than OPK($1.17B). OPK YTD gains are higher at: 24.603 vs. A (8.630). A has higher annual earnings (EBITDA): 2.04B vs. OPK (54.9M). A has more cash in the bank: 1.76B vs. OPK (301M). OPK has less debt than A: OPK (398M) vs A (3.95B). A has higher revenues than OPK: A (7.37B) vs OPK (588M).
AOPKA / OPK
Capitalization41.4B1.17B3,532%
EBITDA2.04B54.9M3,707%
Gain YTD8.63024.60335%
P/E Ratio28.98N/A-
Revenue7.37B588M1,254%
Total Cash1.76B301M584%
Total Debt3.95B398M992%
FUNDAMENTALS RATINGS
A vs OPK: Fundamental Ratings
A
OPK
OUTLOOK RATING
1..100
8386
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
4592
PRICE GROWTH RATING
1..100
4544
P/E GROWTH RATING
1..100
4298
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (11) in the Biotechnology industry is somewhat better than the same rating for OPK (49). This means that A’s stock grew somewhat faster than OPK’s over the last 12 months.

A's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as OPK (100). This means that A’s stock grew similarly to OPK’s over the last 12 months.

A's SMR Rating (45) in the Biotechnology industry is somewhat better than the same rating for OPK (92). This means that A’s stock grew somewhat faster than OPK’s over the last 12 months.

OPK's Price Growth Rating (44) in the Biotechnology industry is in the same range as A (45). This means that OPK’s stock grew similarly to A’s over the last 12 months.

A's P/E Growth Rating (42) in the Biotechnology industry is somewhat better than the same rating for OPK (98). This means that A’s stock grew somewhat faster than OPK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AOPK
RSI
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
59%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 17 days ago
60%
Bullish Trend 11 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
79%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (A: $146.93 vs. OPK: $1.57)
Brand notoriety: A and OPK are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 83% vs. OPK: 134%
Market capitalization -- A: $41.42B vs. OPK: $1.17B
A [@Medical Specialties] is valued at $41.42B. OPK’s [@Medical Specialties] market capitalization is $1.17B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $3.82T. The average market capitalization across the [@Medical Specialties] industry is $18.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 1 FA rating(s) are green while OPK’s FA Score has 0 green FA rating(s).

  • A’s FA Score: 1 green, 4 red.
  • OPK’s FA Score: 0 green, 5 red.
According to our system of comparison, A is a better buy in the long-term than OPK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 4 TA indicator(s) are bullish while OPK’s TA Score has 6 bullish TA indicator(s).

  • A’s TA Score: 4 bullish, 4 bearish.
  • OPK’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, OPK is a better buy in the short-term than A.

Price Growth

A (@Medical Specialties) experienced а -2.61% price change this week, while OPK (@Medical Specialties) price change was -4.27% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.54%. For the same industry, the average monthly price growth was +4.08%, and the average quarterly price growth was +36.27%.

Reported Earning Dates

A is expected to report earnings on Nov 30, 2026.

OPK is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Medical Specialties (-3.54% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
A
Daily Signal:
Gain/Loss:
OPK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEBI12.060.07
+0.58%
Aebi Schmidt Holding Ag
EPSN6.340.03
+0.48%
Epsilon Energy Ltd
EPR59.18-0.15
-0.25%
EPR Properties
LHX245.54-2.83
-1.14%
L3Harris Technologies
ADGM0.56-0.02
-3.28%
Adagio Medical Holdings Inc.

A and

Correlation & Price change

A.I.dvisor indicates that over the last year, A has been closely correlated with TMO. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if A jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To A
1D Price
Change %
A100%
+2.66%
TMO - A
74%
Closely correlated
+1.10%
BRKR - A
72%
Closely correlated
-0.24%
MTD - A
68%
Closely correlated
+1.01%
WAT - A
67%
Closely correlated
+1.67%
RGEN - A
67%
Closely correlated
+0.30%
More